Comparative Effectiveness of Ajamodadi Vataka and Simhanada Guggulu in the Management of Amavata (Rheumatoid Arthritis): An Open Label Double Arm Prospective Clinical Study
Journal of Ayurveda and Integrated Medical Sciences · 15.06.2026 · 11 (5) · 94-99
DOI: 10.21760/jaims.11.5.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 15.06.2026. Verfasst von Lakshmiprasad L. Jadhav und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Amavata, the Ayurvedic correlate of Rheumatoid Arthritis (RA), is a chronic inflammatory joint disorder mediated by the combined vitiation of Ama and Vata Dosha. Both Ajamodadi Vataka and Simhanada Guggulu are classical Ayurvedic formulations prescribed in Amavata, but their comparative efficacy needs systematic evaluation.
Objective
To compare the therapeutic effectiveness of Ajamodadi Vataka and Simhanada Guggulu in subjects diagnosed with Amavata using objective inflammatory markers (ESR, CRP, RA Factor) and the Disease Activity Score-28 (DAS28).
Methods
An open label, double arm, prospective clinical study was conducted on 30 subjects in each group (n = 30 per arm, total n = 60). Group A received Simhanada Guggulu 1 g thrice daily with warm water; Group B received Ajamodadi Vataka granules 4 g thrice daily with warm water for a defined treatment duration. Subjects were assessed at baseline and post-intervention for ESR (mm/hr), CRP (mg/L), RA Factor (IU/mL), DAS28 score, swollen joint count (SJC), tender joint count (TJC), and patient global health assessment. Statistical analysis used the paired t-test for within-group comparisons and the independent samples t-test for between-group comparisons.
Results
Both groups demonstrated statistically significant (p < 0.001) improvements in DAS28 and ESR. Simhanada Guggulu produced a mean DAS28 reduction of 1.00 ± 0.40 (17.9%), while Ajamodadi Vataka produced 1.02 ± 0.29 (19.8%). ESR reduction was 7.80 ± 3.39 mm/hr and 7.30 ± 3.55 mm/hr respectively. Between-group comparison revealed no statistically significant difference in any parameter (p > 0.05).
Conclusion
Both Ajamodadi Vataka and Simhanada Guggulu are equally effective and clinically beneficial in the management of Amavata, with comparable reductions in disease activity, inflammation, and joint pathology.
Zitieren
APA
Jadhav, L. L., & Kore, N. (2026). Comparative Effectiveness of Ajamodadi Vataka and Simhanada Guggulu in the Management of Amavata (Rheumatoid Arthritis): An Open Label Double Arm Prospective Clinical Study. Journal of Ayurveda and Integrated Medical Sciences, 11(5), 94-99. https://doi.org/10.21760/jaims.11.5.15
Vancouver
Jadhav LL, Kore N. Comparative Effectiveness of Ajamodadi Vataka and Simhanada Guggulu in the Management of Amavata (Rheumatoid Arthritis): An Open Label Double Arm Prospective Clinical Study. Journal of Ayurveda and Integrated Medical Sciences. 2026;11(5):94-99. doi:10.21760/jaims.11.5.15
BibTeX
@article{Jadhav2026,
author = {Jadhav, Lakshmiprasad L. and Kore, Naresh},
title = {Comparative Effectiveness of Ajamodadi Vataka and Simhanada Guggulu in the Management of Amavata (Rheumatoid Arthritis): An Open Label Double Arm Prospective Clinical Study},
journal = {Journal of Ayurveda and Integrated Medical Sciences},
year = {2026},
volume = {11},
number = {5},
pages = {94--99},
doi = {10.21760/jaims.11.5.15}
}
EUVIMED